<SEC-DOCUMENT>0001144204-16-129305.txt : 20161025
<SEC-HEADER>0001144204-16-129305.hdr.sgml : 20161025
<ACCEPTANCE-DATETIME>20161025105249
ACCESSION NUMBER:		0001144204-16-129305
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20161025
FILED AS OF DATE:		20161025
DATE AS OF CHANGE:		20161025

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dehaier Medical Systems Ltd
		CENTRAL INDEX KEY:			0001474627
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34661
		FILM NUMBER:		161949584

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 501, JIUZHOU PLAZA
		STREET 2:		83 FUXING ROAD,
		CITY:			HAIDIAN DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100856
		BUSINESS PHONE:		(8610) 5166-0080

	MAIL ADDRESS:	
		STREET 1:		SUITE 501, JIUZHOU PLAZA
		STREET 2:		83 FUXING ROAD,
		CITY:			HAIDIAN DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100856
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>v451153_6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>U.S. SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WASHINGTON, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>For the month of October 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Commission File Number: 001-34661</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Dehaier Medical Systems Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Dehaier Medical Systems Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Room 501, 83 Fuxing Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Haidian District, Beijing 100856</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">People&rsquo;s Republic of China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Address of principal executive offices)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F: Form 20-F&nbsp;&nbsp;<U STYLE="text-decoration: none; vertical-align: baseline"><FONT STYLE="font-family: Wingdings">&#120;</FONT></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On October 25, 2016, Dehaier Medical Systems Limited (the &ldquo;Registrant&rdquo;)
announced several changes in connection with its strategic focus on smart wearable devices. In a press release attached as Exhibit
99.1, the Company announced that (1) the Registrant&rsquo;s name will change from &ldquo;Dehaier Medical Systems Limited&rdquo;
to &ldquo;Lianluo Smart Limited&rdquo;; (2) the Registrant&rsquo;s stock ticker will change from &ldquo;DHRM&rdquo; to &ldquo;LLST&rdquo;;
(3) Mr. Xiaoguang Shen, Mr. Genhui Chen and Ms. Huili (Alisa) Li have resigned from the Board of Directors; (4) Mr. Zhitao He,
Mr. Zhiqiang (Richard) Chang and Mr. Bin Pan have been appointed to serve on the Board of Directors for terms expiring at the annual
shareholder meetings for 2018, 2018 and 2017, respectively; (5) Mr. Ping Chen has resigned as Chairman of the Board of Directors
and Mr. Zhitao He has been appointed to such position; (6) Ms. Huili (Alisa) Li has resigned as Chief Financial Officer of the
Registrant and Ms. Hui Zhou has been appointed to such position and (7) the annual shareholder meeting of the Registrant will be
held on December 20, 2016. The resignations of Mr. Xiaoguang Shen, Mr. Genhui Chen and Ms. Huili (Alisa) Li from the Board of Directors
are not due to any disagreement with the Registrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; padding-right: 5.4pt; padding-left: 0; font-size: 10pt; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="width: 86%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release dated October 25, 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities and Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEHAIER MEDICAL SYSTEMS LIMITED</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 25, 2016</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ping Chen</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ping Chen</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief Executive Officer</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Principal Executive Officer) and</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Duly Authorized Officer</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 48pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; padding-right: 5.4pt; padding-left: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="width: 86%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release dated October 25, 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v451153_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B><U>Exhibit 99.1</U></B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><IMG SRC="image_001.jpg" ALT="" STYLE="height: 60pt; width: 169.5pt">&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Dehaier Changes Name to Lianluo Smart
Limited, Announces Strategic Personnel Adjustment and Announces Date of Annual Shareholder Meeting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">Beijing, China &ndash;October
25, 2016, Dehaier Medical Systems Limited (Nasdaq: DHRM) (the &quot;Company&quot;) announced that its Board of Directors has approved
changing the Company's name to Lianluo Smart Limited to reflect the Company&rsquo;s focus on smart wearable devices. In connection
with the name change, the Company's Nasdaq stock ticker will change from DHRM to LLST. The Company has also appointed new officers
and directors to better align management with the Company's ambition in the field of smart wearable devices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21pt">The Change of the Company's
name shows a more interactive and solid relationship with <FONT STYLE="color: #26282A">Hangzhou Liaison Interactive Information
Technology Co., Ltd. (&quot;Liaison Interactive&quot;)</FONT> that will leverage Liaison Interactive's resources, promote the development
of the Company&rsquo;s intelligent medical business, accelerate its industrial layout on intelligence medical market, and further
optimize its overall business strategies to increase market penetration and acceptance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">To support the Company&rsquo;s
new focus on smart wearable devices, the Board has nominated and elected three new Directors. Former directors Mr. Xiaoguang Shen,
Mr. Genhui Chen and Ms. Huili (Alisa) Li have resigned, and the Board has nominated and elected Mr. Zhitao He, Mr. Zhiqiang (Richard)
Chang and Mr. Bin Pan as Directors. Mr. Pan&rsquo;s term will expire at the annual shareholder meeting to be held in 2017, and
both Mr. He&rsquo;s and Mr. Chang&rsquo;s terms will expire at the 2018 annual shareholder meeting. Mr. Zhitao He will serve as
the Company's new Chairman of the Board, with former Chairman Mr. Ping Chen remaining as CEO and a member of the Board. Mr. Chang
and Mr. Pan are independent directors. Both Mr. Chang and Mr. Pan will serve as members of the Audit, Compensation and Nominating
Committees, with Mr. Chang chairing the Compensation Committee and Mr. Pan chairing the Nominating Committee. Ms. Hui Zhou has
been appointed as the new CFO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">The Company's Chairman
of the Board, Mr. Zhitao He, is also the Chairman of the Board of Liaison Interactive, a China-listed company. Mr. Zhitao He successfully
led Liaison Interactive to list on China&rsquo;s A share market (ticker: 002280). Mr. Zhitao He was named one of the &quot;10
Top Entrepreneurs of Post-1980s&quot; by <I>Hurun Report</I> and &quot;Top Ten Entrepreneurial Leader of Listed Companies&quot;
by <I>Securities Times</I>. In the past two years, under his leadership, Liaison Interactive has moved into the field of smart
hardware, including the purchase of leading American electronics online retailer Newegg <FONT STYLE="color: Blue"><U>(http://www.newegg.com)</U></FONT>,
investments in American virtual reality (&quot;VR&quot;) device manufacturer Avegant <FONT STYLE="color: Blue"><U>(<FONT STYLE="background-color: white">www.avegant.com)
</FONT></U></FONT>and hardware corporation Razer <FONT STYLE="color: Blue"><U>(http://www.razerzone.com<FONT STYLE="background-color: white">)</FONT></U></FONT>,
and promotion of the world's biggest VR Operating System OSVR in China together with Razer. This investment plan has allowed Liaison
Interactive to become a closed loop of &quot;Software and Hardware + Platform + Channels&quot;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">Mr. Richard Chang has
been CEO of Beijing Zhineng Technology Co., Ltd. in Beijing China since October 2015. Prior to that position, he served as a Key
Account Manager and Business VP at AREVA Inc. in Beijing, China from 2013 through October 2015 and Chief Representative and Regional
VP at Ventyx Inc. in Atlanta, Georgia from July 2009 to July 2013. Mr. Chang earned a master&rsquo;s degree in computer science
in 1997 from the University of Texas as Dallas, a master&rsquo;s degree in automation in 1990 from Shanghai Jiaotong University
and a bachelor&rsquo;s degree in automation in 1985 from the same school.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">Mr. Bin Pan is the Chairman
of Shanghai Hubo Investment Management Co., Ltd. He is also the independent director of Hangzhou Liaison Interactive Information
Technology Co. Ltd., Shanghai Yaoji Playing Card Co., Ltd, Shenzhen Prolto Supply Chain Management Co., Ltd and Shanghai Zhixin
Electric Co., Ltd. Mr. Pan is a partner in Shanghai Capital Law &amp; Partners law firm since June, 2004. He used to be the vice-president
at the investment banking division of China Southern Securities Co., Ltd. from March 1997 to June 2004. Mr. Pan earned his master&rsquo;s
degree in International Economic Law from Shanghai University of International Business and Economics in 1997 and his bachelor&rsquo;s
degree in 1994 from Huazhong University of Science and Technology University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">New CFO Ms. Hui Zhou
has 10 years of professional accounting and auditing experience. She previously worked for Ernst &amp; Young, and has strong expertise
in US GAAP, PRC GAAP and IFRS. She led the auditing work of many multinational corporations and prepared initial public offerings
for a variety of companies. She deeply understands Nasdaq trade requirements for listed companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">The Board of Directors
believes that this strategic personnel adjustment will reflect the Company's determination in the business transition. Mr. Zhitao
He has extensive experience in enterprise management and sharp foresight in development of smart hardware ecosystem. The Company
believes that the addition of Mr. Zhitao He will bring new opportunities in the Company's strategic transition and development
of the Company&rsquo;s smart wearable device business. Ms. Hui Zhou&rsquo;s abundant experience in financial management and professional
ability will be a tremendous asset for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">Finally, the Company
has announced that its Annual General Meeting will be held on December 20, 2016. Management looks forward to sharing the Company's
strategy and development plan with shareholders during this meeting. The Company will continue to take full advantage of our considerable
resources in the medical device industry, consolidate existing B2B2C business and expand our market share. Meanwhile, the Company
will leverage the field of wearable devices, which has a potentially large customers base. The Company will constantly update core
algorithm based on big data and continue to research and develop wearable products with combination of software and hardware. The
Company's business now covers multiple areas, including health management, family healthcare, long-distance treatment and sport
and fitness management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.05pt 0pt 0; text-align: justify"><B>About Dehaier Medical Systems
Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">Dehaier Medical develops,
markets and sells medical products, including medical devices and wearable sleep respiratory products in China and international
markets. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components.
Dehaier is committed to becoming the solution provider of medical smart wearable devices and professional services. Dehaier is
transforming from a traditional medical equipment supplier to a high-tech enterprise in the field of mobile medical and smart
wearable devices. The main business of Dehaier is providing overall solutions including accurate screening, efficient treatment
and treatment evaluation for obstructive sleep apnea syndrome (&ldquo;OSAS&rdquo;) patients. With the cutting-edge photoplethysomography
analysis technology and state-of-the-art sleep diagnosis device, Dehaier made the first application of cloud technology in sleep
medicine by managing to upload patients&rsquo; records, patient information management, and analysis to the cloud. Dehaier Medical
provides sleep diagnostic products and services for inpatients and outpatients in Chinese medical institutions including chronic
diseases therapy departments in public hospitals, patients in private physical examination centers and VIP customers of life insurance
companies. Dehaier Medical&rsquo;s technology is based on six patents and eleven software copyrights. More information may be
found at <FONT STYLE="color: Blue"><U>http://www.dehaier.com.cn</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Hangzhou Liaison Interactive Information
Technology Co. Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">Liaison Interactive,
formerly known as Beijing Digital Grid Technology Co., Ltd. was founded in 2007 as a leading mobile Internet product and services
provider in the industry. On October 24, 2014, China Securities Regulatory Commission approved the asset restructuring application
of Beijing Digital Grid Technology Co., ltd. and the listed company Hangzhou New Century Information Technology Co., Ltd. After
the restructuring, listed entity Liaison Interactive (002280) became China&rsquo;s first listed mobile Internet company. Liaison
Interactive has three core business units. Digital Grid Department focuses on innovations in products and technologies. Interactive
Entertainment Department focuses on mobile game developing and operating. Intelligent Hardware Department focuses on one of most
important business strategies striving to be a world-class developer. Based in Beijing, Liaison Interactive has set up subsidiaries
and branches in Shanghai, Guangzhou, Hong Kong, Shenzhen, Hangzhou, Nanjing, Shenyang and the U.S. For more information, please
visit <FONT STYLE="color: Blue"><U>http://www.lianluo.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>For more information, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Dehaier Medical Systems Limited</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mary Li</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">+86 10-5166-0080 ext. 211</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">investors@dehaier.com.cn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !0 .(# 2(  A$! Q$!_\0
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MPJ)/B9U655^Z&4$ @8Z$5@;HR+KQY)I6A^&Y;RS274=8C4A1(8XT.T%F)P2
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MQ*0 0"I!YP/>MRWB2WMXX4+;8U"C<Q8X QR3R?J>M F6****8!1110 4444
M(0#U%,\J,$'8,C&#CTSC^9_.I**+@%)@$8-+10!333X(Y3)&GED\LJ@!6],C
MH2/7K[U<HHHN^HD%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
-** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
